NEW advances in cancer
medicines may not be made
available to Australian cancer
patients in a timely, affordable and
fair manner in the future according
to a new Medicines Australia-sponsored
report by Deloitte Access
Economics.
Presented this week to the
country’s leading cancer specialists
at the Medical Oncology Group
Australia (MOGA) Annual Scientific
Meeting in Melbourne, the
report investigates the significant
challenges currently faced and
those challenges that will continue
to emerge.
It reveals that although Australia
is the cancer capital of the world,
there is a current “misalignment”
between the cancer burden
of disease and healthcare
expenditure.
In 2003 cancer received 13% of
total healthcare expenditure whilst
it was responsible for nearly 20% of
Australia’s burden of disease.The above article was sent to subscribers in Pharmacy Daily's issue from 31 Jul 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Jul 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.